For research use only. Not for therapeutic Use.
MMAD hydrochloride (Cat No.:I002259) is a synthetic compound primarily studied for its potential use in the treatment of psychiatric or neurological disorders. It functions as a psychoactive substance, with activity at monoamine receptors, influencing neurotransmitter systems such as dopamine, serotonin, and norepinephrine. MMAD hydrochloride has been explored for its possible therapeutic effects in mood disorders, depression, and other cognitive conditions. However, its precise pharmacological profile and therapeutic value remain under investigation. Safety, efficacy, and potential side effects are still being assessed through ongoing research and clinical trials.
Catalog Number | I002259 |
CAS Number | 173441-26-4 |
Molecular Formula | C41H67ClN6O6S |
Purity | ≥95% |
Target | Tubulin; ADCs toxin |
Solubility | 10 mM in DMSO |
Storage | -20°C |
IUPAC Name | (2S)-N-[(2S)-1-[[(3R,4S,5S)-3-methoxy-1-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[[(1S)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]-3-methyl-2-(methylamino)butanamide;hydrochloride |
InChI | InChI=1S/C41H66N6O6S.ClH/c1-12-27(6)36(46(9)41(51)35(26(4)5)45-39(50)34(42-8)25(2)3)32(52-10)24-33(48)47-21-16-19-31(47)37(53-11)28(7)38(49)44-30(40-43-20-22-54-40)23-29-17-14-13-15-18-29;/h13-15,17-18,20,22,25-28,30-32,34-37,42H,12,16,19,21,23-24H2,1-11H3,(H,44,49)(H,45,50);1H/t27-,28+,30-,31-,32+,34-,35-,36-,37+;/m0./s1 |
InChIKey | SGRTVTGXHFCGLI-VHQHMVQVSA-N |
SMILES | CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@@H](CC2=CC=CC=C2)C3=NC=CS3)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC.Cl |